TREAT-SC a randomised, double-blinded, placebo-controlled trial of early short course oral dexamethasone for the treatment of sydenham’s chorea in children (117514)

3:45 PM

Kathryn Roberts

The immune landscape of the tonsils: a critical site for understanding Group A Streptococcus infections   (118314)

3:55 PM

Anna Bergonzini

Distribution of serotype and protein vaccine targets in disease-causing GBS in the UK (2009-2023): implications for GBS vaccine rollout (118005)

4:05 PM

Elita Jauneikaite

Three-piece suit: M and M-like proteins as a virulence trio in GAS infections (118583)

4:15 PM

Corentin Bruyns

A novel approach to assess antigen specific Fc-mediated antibody functions induced by Streptococcus pyogenes pharyngitis (118113)

4:25 PM

Kaneka Chheng

Host inflammation plays a critical role in SpeB transcriptional regulation in Group A Streptococcus (117615)

4:35 PM

Stephanie Guerra

The stress of carrying CRISPR-Cas (118164)

4:45 PM

Dorina Haider

Experimental human infection with Streptococcus pyogenes alters the magnitude and phenotype of vaccine antigen-specific memory B cells (116679)

4:55 PM

Holly A Fryer

Adjuvant optimisation is crucial for protective efficacy and immunogenicity of the Group A Streptococcus vaccine candidates Combo#5 and VAX-A1 (118232)

5:05 PM

Johanna Richter